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Previous reports showed that short-term hyperglycemia protects optic nerve axons
in a rat experimental hypertensive glaucoma model. In this study, we investigated
whether short-term hyperglycemia prevents tumor necrosis factor (TNF)-induced optic
nerve degeneration in rats and examined the role of autophagy in this axon change
process. In phosphate-buffered saline (PBS)-treated rat eyes, no significant difference
in axon number between the normoglycemic (NG) and streptozotocin (STZ)-induced
hyperglycemic (HG) groups was seen at 2 weeks. Substantial degenerative changes
in the axons were noted 2 weeks after intravitreal injection of TNF in the NG group.
However, the HG group showed significant protective effects on axons against TNF-
induced optic nerve degeneration compared with the NG group. This protective
effect was significantly inhibited by 3-methyladenine (3-MA), an autophagy inhibitor.
Immunoblot analysis showed that the LC3-II level in the optic nerve was increased
in the HG group compared with the NG group. Increased p62 protein levels in the
optic nerve after TNF injection was observed in the NG group, and this increase was
inhibited in the HG group. Electron microscopy showed that autophagosomes were
increased in optic nerve axons in the HG group. Immunohistochemical study showed
that LC3 was colocalized with nerve fibers in the retina and optic nerve in both the NG
and HG groups. Short-term hyperglycemia protects axons against TNF-induced optic
nerve degeneration. This axonal-protective effect may be associated with autophagy
machinery.
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INTRODUCTION
Glaucoma is a cause of visual field defect due to loss of nerve fibers and thinning of the neuronal
rim of the optic nerve head. The risk factors for glaucoma were defined in epidemiological
studies (Leske et al., 1994, 2008; Sommer and Tielsch, 1996; Francis et al., 2008; Topouzis et al.,
2011). Ocular hypertension, family history, older age, and thinner central corneal thickness
Abbreviations: NG, normoglycemic; HG, hyperglycemic; STZ, streptozotocin; LC3, microtubule-associated protein
light chain 3; POAG, primary open-angle glaucoma; RGC, retinal ganglion cell; TNF, tumor necrosis factor;
PBS, phosphate-buffered saline; 3-MA, 3-methyladenine; DAPI, 4′,6-diamidino-2-phenylindole; DMSO, dimethyl
sulfoxide; TBS, Tris-buffered saline; PSS, physiological saline solution.
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are risk factors for primary open-angle glaucoma (POAG; Leske
et al., 1994, 2008; Sommer and Tielsch, 1996; Coleman and
Miglior, 2008; Francis et al., 2008; Topouzis et al., 2011). It
is believed that diabetes mellitus (DM) also influences the
pathogenesis and progression of glaucoma (Klein et al., 1994;
Leske et al., 1995; Tielsch et al., 1995; Mitchell et al., 1997;
Chopra et al., 2008), although the relationship between DM
and glaucoma remains controversial. Some recent meta-analyses
have shown that DM is risk factor for glaucoma (Zhou et al.,
2014; Zhao et al., 2015). It was determined that the pooled
relative risk of the association between DM and POAG based
on the risk estimate of six cohort studies was 1.40 (Zhou
et al., 2014). In contrast, some studies found that glaucoma
development is inhibited by DM (Gordon et al., 2002; Akkaya
et al., 2014). The Ocular Hypertension Treatment Study showed
that among the 191 participants who reported a history of
DM at baseline, 6 (3.1%) developed POAG compared with
119 (8.3%) of 1427 participants who did not report a history
of DM (Gordon et al., 2002). The univariate hazard ratio for
DM was 0.40 and multivariate hazard ratio was 0.37 (Gordon
et al., 2002). Moreover, a recent study using Heidelberg retina
tomography III has found that rim area and rim volume were
significantly higher in POAG patients with DM compared with
those without DM and suggested the protective effects of DM
against glaucomatous optic nerve damage (Akkaya et al., 2014).
Furthermore, a recent double-blind randomized study has shown
that 50% glucose eye drops significantly improved the mean
contrast sensitivity compared with 0.9% saline in individuals
with POAG (Casson et al., 2014). In the animal models,
short-term hyperglycemia attenuated axonal degeneration and
retinal ganglion cell (RGC) death after experimentally induced
ocular hypertension (Ebneter et al., 2011). Although the results
of that study suggested that the inhibition of microglial
activation is involved in the protective effect of hyperglycemia
(Ebneter et al., 2011), its detailed mechanism remains to be
elucidated.
Autophagy, or cellular self-digestion, is a cellular pathway
involved in protein and organelle degradation which is associated
with the pathophysiology of several human diseases (Mizushima
et al., 2008). In particular, impaired autophagy has been
associated with chronic central nervous system (CNS) diseases
(Margulis and Finkbeiner, 2014; Menzies et al., 2015). Recent
studies have shown that autophagy is activated by short-term
hyperglycemia in Purkinje cells (Yang et al., 2014) and the
gastrocnemius (Lv et al., 2014) in rats, and in astrocytes in
the brain in mice (Zhang et al., 2010). We have recently
demonstrated that the activation of autophagy leads to axonal
protection in the hypertensive experimental glaucoma model
(Kitaoka et al., 2013) and in the tumor necrosis factor (TNF)-
induced optic nerve degeneration model (Kojima et al., 2014).
TNF is involved in certain types of glaucoma (Tezel and Wax,
2000; Yan et al., 2000; Yuan and Neufeld, 2000; Tezel et al., 2001;
Nakazawa et al., 2006; Sawada et al., 2010), and the TNF injection
model may be useful in understanding the mechanism of axonal
degeneration of RGCs (Kitaoka et al., 2006; Munemasa and
Kitaoka, 2013). Therefore, in the present study, we investigated
whether short-term hyperglycemia prevents TNF-induced optic
nerve degeneration and examined the role of autophagy in this
axon change process.
MATERIALS AND METHODS
Animals
Experiments were performed on 8-week-oldmaleWistar rats. All
studies were conducted according to the Association for Research
in Vision and Ophthalmology (ARVO) statement on the Use of
Animals in Ophthalmic and Vision Research and were approved
by the Ethics Committee of the Institute of Experimental Animals
of St. Marianna University Graduate School of Medicine. The
animals were housed in controled conditions, with temperature
at 23± 1◦C, humidity at 55± 5%, and light from 06:00–18:00.
Normoglycemic (NG) and Hyperglycemic
(HG) Models
The rats were divided into two groups. One group received an
intraperitoneal injection of physiological saline solution (PSS) to
serve as the normoglycemic (NG) group and the other received
an intraperitoneal injection of 60 mg/kg streptozotocin (STZ;
Wako, Osaka, Japan) to serve as the HG group. Plasma glucose
levels were measured 4 days after intraperitoneal injection using
One Touch Ultra View (Johnson & Johnson, Tokyo, Japan). Rats
with a plasma glucose level of less than 250 mg/dl in the HG
group were excluded from analysis. Plasma glucose levels were
also measured 1 and 2 weeks after intravitreal injection.
Administration of TNF
Both the NG and HG groups received an intravitreal injection
of TNF 4 days after intraperitoneal injection of PSS or STZ.
Intravitreal injection of TNF was performed as described
previously (Kitaoka et al., 2006, 2009). Briefly, rats were
anesthetized with an intramuscular injection of a mixture of
ketamine-xylazine (10 and 4 mg/kg, respectively). A single 2-µl
injection of 10 ng TNF in 0.01 M PBS, pH 7.40, was administered
intravitreally to the right eye of an animal under a microscope
to avoid lens injury. Phosphate-buffered saline (PBS) alone was
administered to the contralateral left eye as a control. In the
HG group, 60 mM 3-methyladenine (3-MA; Sigma-Aldrich, St.
Louis, MO, USA), an autophagy inhibitor, in dimethyl sulfoxide
(DSMO) was administered simultaneously with TNF into the
right eyes. The rats were euthanized 1 or 2 weeks after the
intravitreal injections with an intraperitoneal overdose of sodium
pentobarbital, followed by enucleation of the eyes.
Immunoblot Analysis
Eighty-four rats were used for immunoblot analysis as described
previously (Kitaoka et al., 2011). Briefly, 1 week after intravitreal
TNF and PBS injection, optic nerves (4 mm in length
starting from immediately behind the globe) were collected,
homogenized, and then centrifuged at 15,000×g for 15 min
at 4◦C. Two optic nerve specimens were pooled into one
sample. Protein concentrations were determined using the Bio-
Rad Protein Assay kit (Bio-Rad, Hercules, CA, USA). Protein
samples (2.5 µg per lane) were subjected to SDS-PAGE on gels
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(Bio-Rad) and transferred to PVDF membranes (Immobilon-
P, Millipore, Billerica, MA, USA). Membranes were blocked
with Tris-buffered saline (TBS)–0.1% Tween-20 containing 5%
skim milk. Membranes were first reacted with anti-microtubule-
associated protein light chain 3 (LC3) antibody (1:200; Medical &
Biological Laboratories Co., Nagoya, Japan), anti-p62 antibody
(1:200; Medical and Biological Laboratories Co.), or anti-β-
actin antibody (1:500; Sigma-Aldrich) in TBS containing 5%
skim milk. Membranes were then sequentially exposed to
peroxidase-labeled anti-rabbit IgG antibody (Cappel, Solon,
OH, USA) or peroxidase-labeled anti-mouse IgG antibody
(Cappel) diluted 1:5000 in Tween-20 in TBS. Western blots
were visualized with an ECL detection system (Amersham ECL
Prime Western Blotting Detection Reagents, GE Healthcare,
Buckinghamshire, UK).
Immunohistochemistry
Seven rats in total were used for immunohistochemical study.
One week after PBS or TNF injection, optic nerve samples
from the NG (3 rats) and HG (4 rats) groups were fixed
by immersion in 10% neutral-buffered formalin for 24 h,
dehydrated, embedded in paraffin, and sectioned (4 µm thick).
Deparaffinized sections were incubated with 1% bovine serum
and then reacted with primary antibodies against LC3 (1:200;
Medical & Biological Laboratories Co.), or neurofilament-L
(a marker of neurons; 1:100; DAKO Corporation, Carpinteria,
CA, USA) diluted in 1% bovine serum overnight at 4◦C. Sections
were then exposed to the following secondary antibodies: FITC-
labeled anti-rabbit antibody (1:100; Cappel, MP Biomedicals,
LLC) or rhodamine-labeled anti-mouse antibody (1:100; Cappel,
MP Biomedicals, LLC). The samples were counterstained with
4′,6-diamidino-2-phenylindole (DAPI; Vesctashield with DAPI,
Vector Laboratories, Inc., Burlingame, CA, USA). Negative
controls were performed by replacing the primary antibody with
PBS or serum.
Axon Counting
Morphometric analysis of each optic nerve was performed as
described previously with samples from 17 rats (Kitaoka et al.,
2009, 2011; Kojima et al., 2014). Eyes were obtained from the
animals 2 weeks after intravitreal injection. Four-millimeter
segments of the optic nerves were obtained starting from 1 mm
behind the globe. These segments of optic nerve were fixed by
immersion in Karnovsky’s solution for 24 h at 4◦C, processed,
and embedded in acrylic resin. Cross sections (1 µm thick)
were cut beginning 1 mm from the globe and stained with
a solution of 1% paraphenylen-diamine (Sigma-Aldrich) in
absolute methanol. For each section, images at the center and
at each quadrant of the periphery (approximately 141.4 µm
from the center) were acquired with a light microscope (BX51;
Olympus, Tokyo, Japan) with a 100× coupled digital camera
(MP5Mc/OL; Olympus) and associated QCapture Pro software
(version 5.1, QImaging, Surrey, Canada). The acquired images
were quantified using Aphelion image-processing software
(version 3.2, ADISC SA and AAI, Inc., Herouville Saint Clair,
France). The number of axons was determined in five distinct
areas of 1446.5 µm2 each (each quadrant of the periphery in
addition to the center; total area of 7232.3 µm2 per eye) from
each eye. The number of axons per eye was averaged and
expressed as the number per square millimeter. A minimum of
four eyes per experimental condition was used for analysis.
Electron Microscopy
Eyes were obtained from animals 2 weeks after intravitreal
injection. Four-millimeter segments of the optic nerves were
obtained starting from 1mmbehind the globe. These segments of
optic nerve were fixed by immersion in Karnovsky’s solution for
24 h at 4◦C, processed, and embedded in acrylic resin. Ultrathin
sections (approximately 100 nm thick) were prepared using
an LKB Ultrotome V (LKB-Produkter AB, Bromma, Sweden),
contrasted with saturated aqueous uranyl acetate and Sato’s
lead solution, and viewed with a JEOL 1200EX transmission
electron microscope (JEOL, Tokyo, Japan) at 80 kV. The number
of autophagosomes was determined in 10 distinct areas of
157.3 µm2 each (total area of 1573 µm2 per eye) from each eye.
Three eyes per experimental condition were used for analysis.
Statistical Analysis
For plasma glucose, data are presented asmean± S.D. Other data
are presented as mean ± S.E.M. Differences among groups were
analyzed using Mann-Whitney’s method. A probability value
of <0.05 was considered to represent a statistically significant
difference.
RESULTS
Effects of STZ on Plasma Glucose Levels
There was no significant difference in baseline plasma glucose
levels (immediately before intraperitoneal injection, day 0)
between the PSS-treated (122.6± 6mg/dl, n = 5) and STZ-treated
groups (121 ± 6.6 mg/dl, n = 6). The plasma glucose levels of
STZ-treated HG rats were significantly increased from 4–18 days
after intraperitoneal injection of STZ compared with those of
PSS-treated NG rats (436.6 ± 59.2 mg/dl and 137 ± 7.5 mg/dl,
STZ and PSS groups, respectively, at 4 days, i.e., immediately
before intravitreal injection, n = 5–6 per group, p < 0.01; 477.5
± 42.1 mg/dl and 172.4 ± 27.6 mg/dl, STZ and PSS groups,
respectively, at 11 days, i.e., 1 week after intravitreal injection,
n = 5–6 per group, p< 0.01; 522.1± 60.1 mg/dl and 136.6± 21.9
mg/dl, STZ and PSS groups, respectively, at 18 days, i.e., 2 weeks
after intravitreal injection, n = 5–6 per group, p< 0.01).
Effects of Hyperglycemia and 3-MA on
TNF-Induced Axonal Degeneration
In PBS-injected eyes, there was no significant difference in axon
number between the HG and NG groups (Figures 1A,C,F).
Compared with PBS-treated eyes, we confirmed substantial
degenerative changes in the axons in the NG group 2 weeks
after TNF injection (Figure 1B), which is consistent with the
findings of our previous studies (Kitaoka et al., 2006, 2009).
The axonal loss after TNF injection was 35% compared with
PBS-injected eyes (Figure 1F). However, HG induction exerted
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FIGURE 1 | Short-term hyperglycemia prevented axon loss in
TNF-induced optic nerve degeneration. Light microscopic findings 2
weeks after (A) PBS injection with NG, (B) 10-ng TNF injection with NG,
(C) PBS injection with HG, (D) 10-ng TNF injection with HG, or (E) 10-ng TNF
injection ±MA with HG. Scale bar = 10 µm (A–E). Effect of hyperglycemia,
TNF, and 3-MA on axon numbers (F) and distribution of axon diameters (G) in
the optic nerves. Each column represents mean ± S.E.M.; n = 4–7 eyes per
group. †p < 0.05 compared with PBS injection with NG; #p < 0.05 compared
with TNF injection with NG; §p < 0.05 compared with TNF injection with HG.
(L), left eyes; (R), right eyes; paired (L) and (R) indicate the same animal.
a significant protective effect against TNF-induced axonal loss
(Figures 1D,F). The HG group showed 84.5% axonal protection
compared with the NG group after TNF injection. Similar trends
were observed in axon diameter profiles (Figure 1G), although
no specific findings were dependent on axon diameter.
Next, we determined the involvement of autophagy in this
protective process. Since previous reports showed that autophagy
is activated by short-term hyperglycemia (Zhang et al., 2010;
Lv et al., 2014; Yang et al., 2014), we examined whether an
autophagy inhibitor would affect this axonal protection. As
shown in Figure 1E, the protective effect was significantly
inhibited by 3-MA, an autophagy inhibitor (Figure 1F). This was
also confirmed in axon diameter profiles (Figure 1G).
Effects of Hyperglycemia, TNF, and 3-MA
on LC3-II and p62 Levels in Optic Nerves
To investigate the effects of hyperglycemia on autophagic status,
we examined the changes in LC3-II, an autophagic marker,
and p62, a multifunctional protein that interacts with a central
component of the autophagy machinery, in the optic nerve.
We previously found that axonal loss started 1 week after
TNF injection (Kitaoka et al., 2006), and the molecular events
before axon loss becomes obvious are important for clarifying
the mechanism of axonal degeneration. In PBS- and TNF-
injected eyes, there were marked increases in LC3-II protein
levels in the optic nerve in HG groups compared with NG groups
(Figure 2A). The increase in LC3-II protein levels in HG group
was significantly inhibited by 3-MA.
In the NG groups, there was a substantial increase in p62
protein levels in optic nerve samples 1 week after TNF injection
(Figure 2B), which is consistent with our previous report in
Kojima et al. (2014). In PBS-treated eyes, there was no significant
difference in p62 protein levels in the optic nerve between the
NG and HG groups (Figure 2B). However, the TNF-induced
upregulation of p62 protein levels in the optic nerve in the NG
FIGURE 2 | LC-3 II and p62 protein levels in optic nerves. Immunoblot
data are normalized to β-actin levels in the same sample. All data are
expressed as a percentage of control. Each column represents mean ±
S.E.M. (A) Immunoblotting for LC-3 II 1 week after intravitreal injection.
n = 5–7 (10–14 eyes) per group. ∗p < 0.05. (B) Immunoblotting for p62 1
week after intravitreal injection. n = 6–9 (12–18 eyes) per group. ∗p < 0.05.
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group was significantly inhibited in the HG group (Figure 2B).
This inhibitory effect of HG induction was not observed in
combination with 3-MA treatment (Figure 2B).
Effects of Hyperglycemia and TNF
on Electron Microscopy Findings
In the NG-PBS group, normal structures of microtubules,
neurofilaments, and myelin were observed, but autophagosomes
were few (Figures 3A,B). In the HG-PBS group, some
autophagosomes were observed inside axons in ε the optic
nerve and the structures of microtubules, neurofilaments,
and myelin were normal (Figures 3C,D). Consistent with our
light microscopy findings showing that degenerative changes
were apparent, degenerative changes such as neurofilament
accumulation and myelin disorganization were observed
in the NG-TNF group (Figures 3E,F). However, these
degenerative changes were inhibited and well-preserved myelin
and microtubule structures were observed in the HG-TNF group
(Figures 3G,H). In addition, some autophagosomes were also
observed in the HG-TNF group (Figures 3G,H). We counted
autophagsome numbers inside axons of the optic nerve. In both
PBS- and TNF-injected eyes, there were significant increases
in autophagosome numbers in the optic nerves in HG groups
compared with NG groups (Figure 3I). These findings are
consistent with the substantial increases in LC3-II protein levels
seen in the optic nerve in HG groups.
LC3 in Nerve Fibers in the Retina and Optic
Nerve
As previously reported in Kim et al. (2008), we observed LC3
immunoreactivity in RGCs in the retina (Figures 4A–E). Double-
labeling immunohistochemical studies showed substantial
colocalization of LC3 and neurofilaments in the retina in NG
and HG rats (Figures 4A–E), suggesting that LC3 is present
not only in RGC bodies but also in their axons. Notably,
LC3-immunopositive dots were observed inside neurofilament-
positive fibers (Figure 4C). In addition, LC3 immunoreactivity
appeared to increase in the optic nerves in the HG-TNF group
compared with that in the NG-TNF group (Figures 5A,B).
Substantial colocalization of LC3 and neurofilaments was also
found in the optic nerves (Figures 5A,B).
DISCUSSION
The present study demonstrated that short-term (2-week)
hyperglycemia does not cause axonal degeneration but instead
exerts axonal protection against TNF-induced optic nerve
degeneration as shown by morphometric analysis of light
microscopic as well as by electron microscopic study results.
This finding is consistent with previous results showing that
short-term hyperglycemia protects retinal neurons including
RGCs against ischemic injury (Casson et al., 2004) and protects
RGCs and optic nerve axons against ocular hypertension injury
(Ebneter et al., 2011). It is also interesting to note that a
recent study has demonstrated that glucose rescued cultured
rat retinal cells from rotenone-induced toxicity via both the
FIGURE 3 | Autophagosomes can be observed in the optic nerve in
short-term hyperglycemia. Electron microscopy findings 2 weeks after
(A,B) PBS injection with NG, (C,D) PBS injection with HG, (E,F) 10-ng TNF
injection with NG, and (G,H) 10-ng TNF injection with HG. Degenerative
changes such as neurofilament accumulation (white asterisks) were noted in
the NG-TNF group (E,F). Autophagosomes (black arrows) were observed in
the HG-PBS group (C,D) and HG-TNF group (G,H). Scale bar = 200 nm.
(I) Comparison of the numbers of autophagosomes. The number of
autophagosomes was determined in 10 distinct areas of 157.3 µm2 each
(total area of 1573 µm2 per eye) from each eye. Each column represents
mean ± S.E.M.; n = 3 eyes per group. ∗p < 0.05.
pentose phosphate pathway and the glycolytic pathway, with the
maintenance of ATP levels and reduced reactive oxygen species
production (Han et al., 2013). On the other hand, we previously
found that astrocytes in the optic nerve were activated after TNF
injection (Kojima et al., 2012). Therefore, one hypothesis is that
TNF enhances glucose utilization by astrocytes and can perturb
their energy metabolism (Yu et al., 1995), thereby impairing the
ability to provide adequate energy for axons.
The roles of autophagy using rapamycin, an autophagy
inducer, and 3-MA, an autophagy inhibitor, on optic nerve
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FIGURE 4 | LC3 is present in nerve fibers in the retina. Double-staining
for LC3 and neurofilaments revealed substantial colocalization in retinal nerve
fibers 1 week after PBS injection in the NG (A) and HG (B) groups, and after
TNF injection in the NG (D) and HG (E) groups. (C) High-magnification view of
the inset image. Note the LC3-immunopositive dots inside
neurofilament-positive fibers (arrows). Scale bar, 50 µm (A,B,D,E) and
25 µm (C).
axons and RGCs in different injuries remain controversial
(Knöferle et al., 2010; Park et al., 2012; Rodríguez-Muela
et al., 2012; Deng et al., 2013). However, our present study
showed that the protective effect of short-term hyperglycemia
was significantly inhibited by 3-MA, suggesting that autophagic
machinery mediates this protective effect. Moreover, our recent
findings that rapamycin exerts axonal protection against TNF-
induced optic nerve degeneration (Kojima et al., 2014) also
support the current findings. In addition, it is noteworthy that
high glucose-induced autophagy protects bone marrow-derived
mesenchymal stem cells from apoptosis (Chang et al., 2015).
The amount of LC3-II correlates closely with autophagosome
number (Mizushima et al., 2010). Our immunoblot analysis
showed substantial increases in LC3-II protein levels in the optic
nerve in HG groups compared with NG groups. Consistent
FIGURE 5 | LC3 is present in the optic nerve. Double-staining for LC3 and
neurofilaments revealed substantial colocalization in the optic nerve 1 week
after TNF injection in the NG (A) and HG (B) groups. Scale bar, 50 µm.
with this, the present electron microscopic study showed that
noticeable autophagosomes were observed in both the HG-PBS
and HG-TNF groups and quantification confirmed that their
number increased. STZ is an antibiotic that can cause pancreatic
β-cell destruction (Wu and Huan, 2008), thereby leading to
low levels of plasma insulin. A previous report showed that
under HG conditions induced by glucose infusion, autophagy
was inhibited in rat skeletal muscle, whereas under STZ-induced
HG conditions, autophagy was enhanced (Lv et al., 2014). This
difference in autophagic status suggests that insulin may regulate
autophagy machinery (Lv et al., 2014). During hyperglycemia,
the administration of insulin reduced LC3-II levels in type 2
diabetes patient muscle (Kruse et al., 2015), implying that low
levels of insulin may lead to increased LC3-II levels. Taken
together, the results suggest that the increases in LC3-II protein
levels in the optic nerve may be associated with autophagy
activation in STZ-induced HG rats that have low levels of insulin.
We observed LC3-immunopositive dots inside
neurofilament-positive fibers near RGC bodies and in the
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 October 2015 | Volume 9 | Article 425
Sase et al. Autophagy and high glucose in the optic nerve
optic nerve. Since LC3 is known to occur on autophagosomes
and widely used as a marker of autophagosomes (Kabeya et al.,
2000; Mizushima et al., 2010), the presence of LC3 in nerve fibers
is consistent with our electron microscopy findings indicating
the presence of autophagosomes inside axons. It is particularly
important to note that autophagosome biogenesis occurs in
distal neurites and then moves mainly retrogradely to cell soma
in dorsal root ganglia neurons (Maday et al., 2012). Although
it is not clear whether this is the case for optic nerve axons and
RGC soma, it is possible that increased LC3 protein levels in the
optic nerve resulted in abundant LC3-immunopositive dots in
all neurofilament-positive fibers in the HG group.
A previous report showed that hyperglycemia does not affect
p62 protein levels in humanmuscle (Kruse et al., 2015). However,
in the present study, the short-term hyperglycemia significantly
inhibited TNF-induced upregulation of p62 protein levels in
the optic nerve. Consistent with this finding, a previous study
demonstrated that the p62 protein level in brain tissue was
significantly decreased in STZ-induced hyperglycemia compared
with normoglycemia in a cerebral ischemic mouse model (Wei
et al., 2013). Since decreased p62 levels indicate enhanced
autophagic flux (Bjørkøy et al., 2009), one possibility is that
STZ-induced hyperglycemia may lead to increased autophagic
flux in the optic nerve. Because we observed a difference
in the p62 level between the NG and HG groups only in
TNF-injected eyes, hyperglycemia may improve autophagic flux
in TNF-induced optic nerve degeneration, although this may
not occur in PBS-injected eyes. It is proposed that enhanced
autophagic flux leads to increasing clearance of unnecessary
proteins and therefore may be beneficial for neuroprotective
interventions in optic neuropathy (Munemasa and Kitaoka,
2015). We only observed axonal protection over the short
term and expect that long-term hyperglycemia will lead to
neurodegeneration, as shown in other neuronal cells that
exhibited autophagic activity impairment and degeneration in
the Purkinje neurons of 24-week STZ-HG rats (Yang et al.,
2014).
In conclusion, our present results suggest that short-term
hyperglycemia protects axons in TNF-induced optic nerve
degeneration and that this axonal-protective effect may be
associated with autophagy machinery.
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